• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.17%

    Acura Pharmaceuticals, Inc. (ACUR)

    -NasdaqCM
    0.52 Up 0.02(3.79%) Dec 24, 12:52PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
    Total Revenue 35   42   35   83  
    Cost of Revenue42  38  36  78  
    Gross Profit (7) 4   (1) 5  
    Operating Expenses
    Research Development1,281  1,438  803  1,289  
    Selling General and Administrative1,916  2,259  2,427  2,302  
    Non Recurring68  133  250  (361)
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (3,272) (3,826) (3,481) (3,225)
    Income from Continuing Operations
    Total Other Income/Expenses Net53  39  73  35  
    Earnings Before Interest And Taxes(3,219)(3,787)(3,408)(3,190)
    Interest Expense302  301  9   -  
    Income Before Tax(3,521)(4,088)(3,417)(3,190)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(3,521)(4,088)(3,417)(3,190)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (3,521) (4,088) (3,417) (3,190)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (3,521) (4,088) (3,417) (3,190)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.